Ionis Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Ionis Pharmaceuticals, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.710.790.590.810.731.120.60
Cost of Revenue0.910.010.010.650.010.000.00
Gross Profit-0.210.780.570.160.721.120.60
Operating Expenses
Research & Development0.900.900.830.640.530.460.41
Selling, General & Administrative0.270.230.150.190.350.290.24
Operating Expenses0.271.130.980.190.350.290.66
Operating Income-0.48-0.35-0.41-0.03-0.170.37-0.06
Other Income/Expense
Interest Income0.110.090.030.010.030.000.00
Interest Expense-0.090.080.01-0.01-0.010.000.04
Other Income/Expense0.000.100.160.00-0.05-0.030.03
Income
Income Before Tax-0.46-0.33-0.26-0.03-0.130.35-0.08
Income Tax Expense-0.010.030.010.000.350.04-0.29
Net Income-0.45-0.37-0.27-0.03-0.440.290.27
Net Income - Continuous Operations-0.45-0.37-0.27-0.030.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-0.46-0.24-0.23-0.01-0.110.44-0.02
EBIT-0.48-0.26-0.25-0.03-0.130.40-0.03
Depreciation & Amortization0.010.020.020.020.020.000.00
Earnings Per Share
Basic EPS-3.00-3.00-2.00--3.002.002.00
Diluted EPS-3.00-3.00-2.00--3.002.002.00
Basic Shares Outstanding0.150.140.140.140.140.140.13
Diluted Shares Outstanding0.150.140.140.140.140.140.13